792
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA

, , , , , , & show all
Pages 498-506 | Received 08 Mar 2012, Accepted 24 Apr 2012, Published online: 23 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Vida Ungerer, Abel J. Bronkhorst & Stefan Holdenrieder. (2020) Preanalytical variables that affect the outcome of cell-free DNA measurements. Critical Reviews in Clinical Laboratory Sciences 57:7, pages 484-507.
Read now
Abel Jacobus Bronkhorst, Vida Ungerer & Stefan Holdenrieder. (2020) Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations. Critical Reviews in Clinical Laboratory Sciences 57:4, pages 253-269.
Read now
Hongjuan Zhao, Rosalie Nolley, Andy M. W. Chan, Erinn B. Rankin & Donna M. Peehl. (2017) Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation. Cancer Biology & Therapy 18:11, pages 863-871.
Read now
Cindy Kin, Evelyn Kidess, George A Poultsides, Brendan C Visser & Stefanie S Jeffrey. (2013) Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Review of Molecular Diagnostics 13:6, pages 581-599.
Read now

Articles from other publishers (22)

Abel J. Bronkhorst11 & Stefan Holdenrieder11. (2023) The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization. Medizinische Genetik 35:4, pages 201-235.
Crossref
Benedetta Cena, Emmanuel Melloul, Nicolas Demartines, Olivier Dormond & Ismail Labgaa. (2022) Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?. International Journal of Molecular Sciences 23:10, pages 5343.
Crossref
Nitza Burck, Tal Gilboa, Abhilash Gadi, Michelle Patkin Nehrer, Robert J Schneider & Amit Meller. (2021) Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation. Clinical Chemistry 67:5, pages 753-762.
Crossref
Yan-yan Yan, Qiao-ru Guo, Feng-hua Wang, Rameshwar Adhikari, Zhuang-yan Zhu, Hai-yan Zhang, Wen-min Zhou, Hua Yu, Jing-quan Li & Jian-ye Zhang. (2021) Cell-Free DNA: Hope and Potential Application in Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Beenish Rahat, Taqveema Ali, Divika Sapehia, Aatish Mahajan & Jyotdeep Kaur. (2020) Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine. Frontiers in Genetics 11.
Crossref
Abel Jacobus Bronkhorst, Vida Ungerer & Stefan Holdenrieder. (2019) The emerging role of cell-free DNA as a molecular marker for cancer management. Biomolecular Detection and Quantification 17, pages 100087.
Crossref
Caitlin M. Stewart & Dana W.Y. Tsui. (2018) Circulating cell-free DNA for non-invasive cancer management. Cancer Genetics 228-229, pages 169-179.
Crossref
Grant C O’ConnellPaul D ChantlerTaura L Barr. (2017) High Interspecimen Variability in Nucleic Acid Extraction Efficiency Necessitates the Use of Spike-In Control for Accurate qPCR-based Measurement of Plasma Cell-Free DNA Levels. Laboratory Medicine 48:4, pages 332-338.
Crossref
Jonathan C. M. Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D. Brenton, Carlos Caldas, Simon Pacey, Richard Baird & Nitzan Rosenfeld. (2017) Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer 17:4, pages 223-238.
Crossref
D.S. Pisetsky. 2017. Chromatin Remodelling and Immunity. Chromatin Remodelling and Immunity 113 137 .
Alastair Greystoke, Mahmood Ayub, Dominic G. Rothwell, Dan Morris, Deborah Burt, Cassandra L. Hodgkinson, Christopher J. Morrow, Nigel Smith, Kyaw Aung, Juan Valle, Louise Carter, Fiona Blackhall, Caroline Dive & Ged Brady. (2016) Development of a circulating miRNA assay to monitor tumor burden: From mouse to man. Molecular Oncology 10:2, pages 282-291.
Crossref
Hongbiao Lu, Jonas Busch, Monika Jung, Silke Rabenhorst, Bernhard Ralla, Ergin Kilic, Steffen Mergemeier, Nils Budach, Annika Fendler & Klaus Jung. (2016) Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients. Clinica Chimica Acta 452, pages 109-119.
Crossref
Rene Cortese, Isaac Almendros, Yang Wang & David Gozal. (2014) Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia. Oncotarget 6:1, pages 556-569.
Crossref
Florent Mouliere, Alain R. Thierry & Christian Larroque. 2015. Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring. Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring 89 111 .
Michael Fleischhacker & Bernd Schmidt. 2015. Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring. Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring 239 293 .
Györgyi Műzes, Ferenc Sipos, István Fűri, Miklós Constantinovits, Sándor Spisák, Barnabás Wichmann, Gábor Valcz, Zsolt Tulassay & Béla Molnár. (2014) Preconditioning with Intravenous Colitic Cell-Free DNA Prevents DSS-Colitis by Altering TLR9-Associated Gene Expression Profile. Digestive Diseases and Sciences 59:12, pages 2935-2946.
Crossref
Ferenc Sipos, Györgyi Műzes, István Fűri, Sándor Spisák, Barnabás Wichmann, Tiana M. Germann, Miklós Constantinovits, Tibor Krenács, Zsolt Tulassay & Béla Molnár. (2014) Intravenous Administration of a Single-Dose Free-Circulating DNA of Colitic Origin Improves Severe Murine DSS-Colitis. Pathology & Oncology Research 20:4, pages 867-877.
Crossref
Florent Mouliere, Safia El Messaoudi, Dalong Pang, Anatoly Dritschilo & Alain R. Thierry. (2014) Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer. Molecular Oncology 8:5, pages 927-941.
Crossref
Alberto Ramírez, Houria Boulaiz, Cynthia Morata-Tarifa, Macarena Perán, Gema Jiménez, Manuel Picon-Ruiz, Ahmad Agil, Olga Cruz-López, Ana Conejo-García, Joaquín M. Campos, Ana Sánchez, María A. García & Juan A. Marchal. (2014) HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib. Oncotarget 5:11, pages 3590-3606.
Crossref
W. SUN, Y. SUN, M. ZHU, Z. WANG, H. ZHANG, Y. XIN, G. JIANG, X. GUO, Z. ZHANG & Y. LIU. (2014) The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients. Oncology Reports 31:3, pages 1466-1472.
Crossref
Dolores C García-Olmo, María G Picazo, Inmaculada Toboso, Ana I Asensio & Damián García-Olmo. (2013) Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats. Molecular Cancer 12:1.
Crossref
Svetlana V. Kostyuk, Marina S. Konkova, Elizaveta S. Ershova, Anna J. Alekseeva, Tatiana D. Smirnova, Sergey V. Stukalov, Ekaterina A. Kozhina, Nadezda V. Shilova, Tatiana V. Zolotukhina, Zhanna G. Markova, Vera L. Izhevskaya, Ancha Baranova & Natalia N. Veiko. (2013) An Exposure to the Oxidized DNA Enhances Both Instability of Genome and Survival in Cancer Cells. PLoS ONE 8:10, pages e77469.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.